Literature DB >> 16153873

Trypanosoma cruzi surface molecule gp90 downregulates invasion of gastric mucosal epithelium in orally infected mice.

Mauro Cortez1, Marcelo R Silva, Ivan Neira, Daniele Ferreira, Gisela R S Sasso, Alejandro O Luquetti, Anis Rassi, Nobuko Yoshida.   

Abstract

Experiments were performed to elucidate why Trypanosoma cruzi isolates 573 and 587 differ widely in their efficiency to infect gastric mucosal epithelium when administered orally to mice. These isolates have the same surface profile and a similar capacity to enter host cells in vitro. Metacyclic forms of isolates 573 and 587 and the control CL isolate expressed similar levels of gp82, which is a cell invasion-promoting molecule. Expression of gp90, a molecule that downregulates cell invasion, was lower in the CL isolate. Consistent with this profile, approximately threefold fewer parasites of isolates 573 and 587 entered epithelial HeLa cells, as compared to the CL isolate. No difference in the rate of intracellular parasite replication was observed between isolates. When given orally to mice, metacyclic forms of isolate 573, like the CL isolate, produced high parasitemia (>10(6) parasites per ml at the peak), killing approximately 40% of animals, whereas infection with isolate 587 resulted in low parasitemia (<10(5) parasites per ml), with zero mortality. On the fourth day post-inoculation, tissue sections of the mouse stomach stained with hematoxylin and eosin showed a four to sixfold higher number of epithelial cells infected with isolate 573 or CL than with isolate 587. The rate of intracellular parasite development was similar in all isolates. Mimicking in vivo infection, parasites were treated with pepsin at acidic pH and then assayed for their ability to enter HeLa cells or explanted gastric epithelial cells. Pepsin extensively digested gp90 from isolate 573 and significantly increased invasion of both cells, but had minor effect on gp90 or infectivity of isolates 587 and CL. The profile of g82 digestion was similar in isolates 573 and 587, with partial degradation to a approximately 70 kDa fragment, which preserved the target cell binding domain as well as the region involved in gastric mucin adhesion. Gp82 from CL isolate was resistant to pepsin. Assays with parasites recovered from the mouse stomach 2 h after oral infection showed an extensive digestion of gp90 and increased infectivity of isolate 573, but not of isolate 587 or CL. Our data indicate that T. cruzi infection in vitro does not always correlate with in vivo infection because host factors may act on parasites, modulating their infectivity, as is the case of pepsin digestion of isolate 573 gp90.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153873     DOI: 10.1016/j.micinf.2005.05.016

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  17 in total

1.  Expression and cellular localization of molecules of the gp82 family in Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  Vanessa D Atayde; Mauro Cortez; Renata Souza; José Franco da Silveira; Nobuko Yoshida
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

2.  Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi.

Authors:  Daniela I Staquicini; Rafael M Martins; Silene Macedo; Gisela R S Sasso; Vanessa D Atayde; Maria A Juliano; Nobuko Yoshida
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

3.  Oral infection of mice and host cell invasion by Trypanosoma cruzi strains from Mexico.

Authors:  Cecilia G Barbosa; César Gómez-Hernández; Karine Rezende-Oliveira; Marcos Vinicius Da Silva; João Paulo Ferreira Rodrigues; Monique G S Tiburcio; Thatiane Bragini Ferreira; Virmondes Rodrigues; Nobuko Yoshida; Luis E Ramirez
Journal:  Parasitol Res       Date:  2019-03-08       Impact factor: 2.289

4.  Oral transmission of Trypanosoma cruzi with opposing evidence for the theory of carnivory.

Authors:  Dawn M Roellig; Angela E Ellis; Michael J Yabsley
Journal:  J Parasitol       Date:  2009-04       Impact factor: 1.276

5.  Molecular characterization of serine-, alanine-, and proline-rich proteins of Trypanosoma cruzi and their possible role in host cell infection.

Authors:  Renata C P Baida; Márcia R M Santos; Mirian S Carmo; Nobuko Yoshida; Danielle Ferreira; Alice Teixeira Ferreira; Najib M El Sayed; Bjorn Andersson; José Franco da Silveira
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

6.  Rab5 activation by Toll-like receptor 2 is required for Trypanosoma cruzi internalization and replication in macrophages.

Authors:  Elena Maganto-Garcia; Carmen Punzon; Cox Terhorst; Manuel Fresno
Journal:  Traffic       Date:  2008-04-28       Impact factor: 6.215

7.  Differential infectivity by the oral route of Trypanosoma cruzi lineages derived from Y strain.

Authors:  Cristian Cortez; Rafael M Martins; Renan M Alves; Richard C Silva; Luciana C Bilches; Silene Macedo; Vanessa D Atayde; Silvia Y Kawashita; Marcelo R S Briones; Nobuko Yoshida
Journal:  PLoS Negl Trop Dis       Date:  2012-10-04

8.  Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection in Mice: New Disease Form from an Old Infection?

Authors:  Juliana Barreto-de-Albuquerque; Danielle Silva-dos-Santos; Ana Rosa Pérez; Luiz Ricardo Berbert; Eliane de Santana-van-Vliet; Désio Aurélio Farias-de-Oliveira; Otacilio C Moreira; Eduardo Roggero; Carla Eponina de Carvalho-Pinto; José Jurberg; Vinícius Cotta-de-Almeida; Oscar Bottasso; Wilson Savino; Juliana de Meis
Journal:  PLoS Negl Trop Dis       Date:  2015-06-19

9.  Structural basis of the interaction of a Trypanosoma cruzi surface molecule implicated in oral infection with host cells and gastric mucin.

Authors:  Cristian Cortez; Nobuko Yoshida; Diana Bahia; Tiago J P Sobreira
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Trypanosoma cruzi Entrance through Systemic or Mucosal Infection Sites Differentially Modulates Regional Immune Response Following Acute Infection in Mice.

Authors:  Juliana de Meis; Juliana Barreto de Albuquerque; Danielle Silva Dos Santos; Désio Aurélio Farias-de-Oliveira; Luiz Ricardo Berbert; Vinícius Cotta-de-Almeida; Wilson Savino
Journal:  Front Immunol       Date:  2013-07-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.